Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

vTv Therapeutics (VTVT) Net Income towards Common Stockholders (2016 - 2025)

vTv Therapeutics (VTVT) has disclosed Net Income towards Common Stockholders for 12 consecutive years, with -$7.1 million as the latest value for Q4 2025.

  • Quarterly Net Income towards Common Stockholders fell 96.42% to -$7.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$27.0 million through Dec 2025, down 46.11% year-over-year, with the annual reading at -$27.0 million for FY2025, 46.11% down from the prior year.
  • Net Income towards Common Stockholders hit -$7.1 million in Q4 2025 for vTv Therapeutics, up from -$8.7 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of -$608000.0 in Q2 2021 to a low of -$8.7 million in Q3 2025.
  • Historically, Net Income towards Common Stockholders has averaged -$5.0 million across 5 years, with a median of -$5.0 million in 2024.
  • Biggest YoY gain for Net Income towards Common Stockholders was 87.82% in 2021; the steepest drop was 538.77% in 2021.
  • Year by year, Net Income towards Common Stockholders stood at -$7.1 million in 2021, then soared by 32.7% to -$4.7 million in 2022, then grew by 26.7% to -$3.5 million in 2023, then decreased by 4.49% to -$3.6 million in 2024, then tumbled by 96.42% to -$7.1 million in 2025.
  • Business Quant data shows Net Income towards Common Stockholders for VTVT at -$7.1 million in Q4 2025, -$8.7 million in Q3 2025, and -$6.0 million in Q2 2025.